Información del artículo
El Texto completo está disponible en PDF
References
[1.]
M. Vaxillaire, P. Froguel.
Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes.
Endocr Rev, 29 (2008), pp. 254-264
[2.]
M. Polak, J. Shield.
Neonatal and very-early-onset diabetes mellitus.
Seminars in Neonatalogy, 9 (2004), pp. 59-65
[3.]
F. Barbetti.
Diagnosis of neonatal and infancy-onset diabetes.
Endocr Dev, 11 (2007), pp. 83-93
[4.]
E.R. Pearson, I. Flechtner, P.R. Njølstad, M.T. Malecki, S.E. Flanagan, B. Larkin, et al.
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
N Engl J Med, 355 (2006), pp. 467-477
[5.]
I. Flechtner, M. Vaxillaire, H. Cavé, R. Scharfmann, P. Froguel, M. Polak.
Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
Endocr Dev, 12 (2007), pp. 86-98
[6.]
R. Murphy, S. Ellard, A.T. Hattersley.
Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.
Nat Clin Pract Endocrinol Metab, 4 (2008), pp. 200-213
[7.]
A.P. Babenko, M. Polak, H. Cavé, K. Busiah, R. Scharfmann, J. Bryan, et al.
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
N Engl J Med, 355 (2006), pp. 456-466
[8.]
M. Polak, A. Dechaume, H. Cavé, R. Nimri, H. Crosnier, V. Sulmont, et al.
Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
Diabetes, 57 (2008), pp. 1115-1119
[9.]
A.L. Gloyn, E.R. Pearson, J.F. Antcliff, P. Proks, G.J. Bruining, A.S. Slingerland, et al.
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
N Engl J Med, 350 (2004), pp. 1838-1849
[10.]
J. Stoy, E.L. Edghill, S.E. Flanagan, H. Ye, V.P. Paz, A. Pluzhnikov, et al.
Insulin gene mutations as a cause of permanent neonatal diabetes.
Proc Natl Acad Sci USA, 104 (2007), pp. 15040-15044
[11.]
C. Bellanne-Chantelot, D. Chauveau, J.F. Gautier, D. Dubois-Laforgue, S. Clauin, S. Beaufils, et al.
Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations.
Ann Intern Med, 140 (2004), pp. 510-517
[12.]
P. Froguel, H. Zouali, N. Vionnet, G. Velho, M. Vaxillaire, F. Sun, et al.
Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
N Engl J Med, 328 (1993), pp. 697-702
[13.]
L. Aguilar-Bryan, J. Bryan.
Molecular biology of adenosine triphosphate- sensitive potassium channels.
Endocr Rev, 20 (1999), pp. 101-135
[14.]
A.I. Tarasov, T.J. Nicolson, J.P. Riveline, T.K. Taneja, S.A. Baldwin, J.M. Baldwin, et al.
A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
Diabetes, 57 (2008), pp. 1595-1604
[15.]
C. Colombo, O. Porzio, M. Liu, O. Massa, M. Vasta, S. Salardi, et al.
Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.
J Clin Invest, 118 (2008), pp. 2148-2156
Copyright © 2009. Sociedad Española de Endocrinología y Nutrición
